IMV stock gained in the Pre-market, here is why?
The stock of IMV Inc. (IMV) gained in the pre-market after the company announced that its first patient was dosed in the VITALIZE Phase 2B clinical trial in a press release. The stock of IMV was valued at around $1.31 in the pre-market gaining more than 3.97% from the previously closed value. At the end […]
